Divi's Laboratories (NSE:DIVISLAB) Purchase Of Investment : ₹0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Purchase Of Investment?

Divi's Laboratories's purchase of investment for the three months ended in Dec. 2023 was ₹0 Mil. It means Divi's Laboratories spent ₹0 Mil on purchasing investments. Divi's Laboratories's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2023 ), Divi's Laboratories spent the same money on purchasing investments in Dec. 2023 (₹0 Mil).

Divi's Laboratories Purchase Of Investment Historical Data

The historical data trend for Divi's Laboratories's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Purchase Of Investment Chart

Divi's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Purchase Of Investment

Get a 7-Day Free Trial

-9,662.30

-5,332.80

-2,139.40

-15,990.30

-40,403.80

Divi's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Divi's Laboratories Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Divi's Laboratories Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Purchase Of Investment

Traded in Other Exchanges

532488:India

Address

Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines